Leerink Partners Remains a Buy on Century Therapeutics (IPSC)
Leerink Partners analyst Daina Graybosch maintained a Buy rating on Century Therapeutics (IPSC – Research Report) yesterday and set a price ...
Stifel cuts IPG Photonics target to $85, maintains Buy rating
Stifel analysts took a cautious stance on IPG Photonics (NASDAQ:IPGP), revising the company's price target downward to $85 from the previous target of $100. Despite the reduction, Stifel continues to ...